Influence of imidazole replacement in different structural classes of histamine H3-receptor antagonists

被引:100
作者
Meier, G
Apelt, J
Reichert, U
Grassmann, S
Ligneau, X
Elz, S
Leurquin, F
Ganellin, CR
Schwartz, JC
Schunack, W
Stark, H
机构
[1] Free Univ Berlin, Inst Pharm, D-14195 Berlin, Germany
[2] Lab Bioproject, F-75003 Paris, France
[3] UCL, Christopher Ingold Labs, Dept Chem, London WC1H OAJ, England
[4] INSERM, Ctr Paul Broca, Unite Neurobiol & Pharmacol Mol, U109, F-75014 Paris, France
[5] Univ Frankfurt, Inst Pharmazeut Chem, D-60439 Frankfurt, Germany
关键词
histamine; H(3) receptor; imidazole; non-imidazole; antagonist; medicinal chemistry;
D O I
10.1016/S0928-0987(01)00106-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The reference compounds for histamine H(3)-receptor antagonists carry as a common feature an imidazole moiety substituted in the 4-position. Very recently novel ligands lacking an imidazole ring have been described possessing a N-containing non-aromatic heterocycle instead. In this study we investigated whether imidazole replacement, favourably by a piperidine moiety, is generally applicable to different structural classes of reference compounds, e.g., thioperamide, carboperamide, clobenpropit, FUB 181, ciproxifan, etc. While replacement led to a loss of affinity for many of the compounds, it was successfully applied to some ether derivatives. The piperidine analogues of FB 181 and ciproxifan, 3-(4-chlorophenyl)propyl 3-piperidinopropyl ether hydrogen oxalate (6) and cyclopropyl 4-(3-piperidinopropyloxy)phenyl methanone hydrogen maleate (7), almost maintained in vitro affinities, pK(i) values of 7.8 and 8.4, respectively, and showed high potency in vivo after p.o. administration (ED(50) values of 1.6 and 0.18 mg/kg, respectively). (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:249 / 259
页数:11
相关论文
共 61 条
[1]   Design, synthesis, and structure-activity relationships of acetylene-based histamine H3 receptor antagonists [J].
Ali, SM ;
Tedford, CE ;
Gregory, R ;
Handley, MK ;
Yates, SL ;
Hirth, WW ;
Phillips, JG .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (05) :903-909
[2]   [H-3]-thioperamide as a radioligand for the histamine H-3 receptor in rat cerebral cortex [J].
AlvesRodrigues, A ;
Leurs, R ;
Wu, TS ;
Prell, GD ;
Foged, C ;
Timmerman, H .
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 118 (08) :2045-2052
[3]   AUTO-REGULATION OF HISTAMINE-RELEASE IN BRAIN BY PRESYNAPTIC H-3-RECEPTORS [J].
ARRANG, JM ;
GARBARG, M ;
SCHWARTZ, JC .
NEUROSCIENCE, 1985, 15 (02) :553-562
[4]   AUTOINHIBITION OF HISTAMINE SYNTHESIS MEDIATED BY PRESYNAPTIC H-3 RECEPTORS [J].
ARRANG, JM ;
GARBARG, M ;
SCHWARTZ, JC .
NEUROSCIENCE, 1987, 23 (01) :149-157
[5]   HIGHLY POTENT AND SELECTIVE LIGANDS FOR HISTAMINE RECEPTORS-H-3 [J].
ARRANG, JM ;
GARBARG, M ;
LANCELOT, JC ;
LECOMTE, JM ;
POLLARD, H ;
ROBBA, M ;
SCHUNACK, W ;
SCHWARTZ, JC .
NATURE, 1987, 327 (6118) :117-123
[6]   Inhibition of cortical acetylcholine release and cognitive performance by histamine H-3 receptor activation in rats [J].
Blandina, P ;
Giorgetti, M ;
Bartolini, L ;
Cecchi, M ;
Timmerman, H ;
Leurs, R ;
Pepeu, G ;
Giovannini, MG .
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 119 (08) :1656-1664
[7]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[8]   SULFUR-CONTAINING AMINES .8. LOCAL ANESTHETICS .3. [J].
CLINTON, RO ;
SALVADOR, UJ ;
LASKOWSKI, SC .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1949, 71 (10) :3366-3370
[9]   Novel 1,2,4-oxadiazoles as potent and selective histamine H-3 receptor antagonists [J].
Clitherow, JW ;
Beswick, P ;
Irving, WJ ;
Scopes, DIC ;
Barnes, JC ;
Clapham, J ;
Brown, JD ;
Evans, DJ ;
Hayes, AG .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (07) :833-838
[10]   Synthesis and histamine H3 receptor activity of 4-(n-alkyl)-1H-imidazoles and 4-(ω-phenylalkyl)-1H-imidazoles [J].
De Esch, IJP ;
Gaffar, A ;
Menge, WMPB ;
Timmerman, H .
BIOORGANIC & MEDICINAL CHEMISTRY, 1999, 7 (12) :3003-3009